News
CYRX
29.84
+0.35%
0.11
CryoPort Earnings Perspective: Return On Invested Capital
According to data from Benzinga Pro, during Q1, CryoPort's (NASDAQ:CYRX) reported sales totaled $52.30 million. Despite a 94.85% increase in earnings, the company posted a loss of $13.40 million.
Benzinga · 05/26 13:51
B. Riley Lowers Cryoport's Price Target to $55 from $61 to Reflect Updated Required Returns, Keeps Buy Rating
MT Newswires · 05/17 09:27
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 807 companies reached new 52-week lows.
Benzinga · 05/11 16:28
Expert Ratings for CryoPort
Over the past 3 months, 5 analysts have published their opinion on CryoPort (NASDAQ:CYRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the ...
Benzinga · 05/06 14:03
--KeyBanc Adjusts Cryoport's Price Target to $52 from $92, Keeps Overweight Rating
MT Newswires · 05/06 12:46
--Needham Adjusts Cryoport's Price Target to $41 From $45, Reiterates Buy Rating
MT Newswires · 05/06 07:39
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/05 23:05
BRIEF-Cryoport Q1 Loss Per Share $0.31
reuters.com · 05/05 23:01
CryoPort Q1 EPS $(0.31) Misses $(0.22) Estimate, Sales $52.80M Miss $52.86M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.22) by 40.91 percent. This is a 138.46 percent decrease over losses of $(0.13) per share from the
Benzinga · 05/05 20:58
-- Earnings Flash (CYRX) CRYOPORT Posts Q1 Revenue $52.3M, vs. Street Est of $52.9M
MT Newswires · 05/05 16:27
--B. Riley Lowers Cryoport's Price Target to $61 from $70 to Reflect Higher Required Return in Market, Keeps Buy Rating
MT Newswires · 05/05 09:39
Earnings Preview For CryoPort
CryoPort (NASDAQ:CYRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that CryoPort will report an earnings per share (EPS) of $-0.22.
Benzinga · 05/04 16:21
--Roth Capital Adjusts Cryoport's Price Target to $67 from $90
MT Newswires · 05/03 12:42
Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the three months period ended M...
PR Newswire · 04/28 12:30
Cryoport, Cryogene growing Houston presence with new supply chain, logistics facility
The firm stores and moves temperature-controlled specimens for customers in biopharmaceuticals, animal husbandry, reproductive medicine, government agencies and more.
American City Business Journals · 04/19 16:24
Cryoport pays nearly $7 million for France-based Cell&Co BioServices
The deal follows a string of international buys over the past two years for Cryoport, which most recently bought Brussels-based F-Airgate in May.
American City Business Journals · 04/18 19:11
Life sciences industry logistics provider Cryoport acquires Cell&Co BioServices
Cryoport (NASDAQ:CYRX), a provider of logistics and supply chain solutions for the life sciences industry, on Monday said it acquired Cell&Co BioServices, a business providing biorepository, kitting, and logistics services.
Seekingalpha · 04/18 13:02
BRIEF-Cryoport Acquires Cell&Co Bioservices
reuters.com · 04/18 12:35
Cryoport Acquires Cell&Co BioServices For €6.2M
Acquisition of Cell&Co BioServices, Clermont-Ferrand, France, accelerates Company's EMEA expansion plans and development of its Global Supply Chain Network NASHVILLE, Tenn., April 18, 2022 /PRNewswire/ --
Benzinga · 04/18 12:31
Cryoport Acquires Cell&Co BioServices for $6.7 Million; Shares Dip Early
MT Newswires · 04/18 09:51
More
Webull provides a variety of real-time CYRX stock news. You can receive the latest news about Cryoport Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYRX
Cryoport, Inc. is a provider of integrated temperature-controlled supply-chain solutions to the biopharma/pharma, animal health, and reproductive medicine markets. The Company provides supply chain technologies and services through its brands, such as Cryoport Systems, CryoStork, MVE Biological Solutions, CRYOPDP, and CRYOGENE. The Company's products include Cryoport Express Shippers, Cryoport ELITE Shippers, Cryoport Cryosphere, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature Controlled Logistics, CRYOPDP Direct to Patient Solutions, CRYOPDP Control Tower Solution, MVE Biological Solutions Fusion Cryogenic Freezers and MVE Biological Solutions Vario Cryogenic Freezer. It operates primarily in Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC). Its subsidiaries include Cryoport Systems, LLC, Cryogene, Inc., MVE Biological Solutions, US LLC, Cryoport Netherlands B.V., and Cell&Co BioServices.